Products ProstaScint® ProstaScint® is an imaging agent that can help locate and identify previously diagnosed prostate cancer. ProstaScint® is a monoclonal antibody combined with a small amount of radioactive material called indium-111 (In 111). As ProstaScint® circulates through the body, it attaches to Prostate Specific Membrane Antigen (PSMA) which is located on prostate cancer cells. These areas of attachment are visible to a gamma camera that can detect radiation given off by the indium-111. Using this technology, pictures or images will be produced showing prostate cancer. ProstaScint® is available in the U.S. For more information on ProstaScint® please visit www.prostascintimaging.com. For information on our products, where they are available and prescribing information, please see the Product Summary table.
|
|
|
Important Safety Information: Patient management should not be based on ProstaScint® scan results without appropriate confirmatory studies since in the pivotal trials, there was a high rate of false positive and false negative image interpretations. ProstaScint images should be interpreted only by physicians who have had specific training in ProstaScint image interpretation. Medications for the treatment of hypersensitivity reactions should be available during administration of this agent. |
|
| Back to home page | Legal | Privacy Policy |
